Drug Shortage Report for LABETALOL HYDROCHLORIDE INJECTION USP

Last updated on 2019-02-04 History
Report ID 70256
Drug Identification Number 02231689
Brand name LABETALOL HYDROCHLORIDE INJECTION USP
Common or Proper name LABETALOL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) LABETALOL HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS
Packaging size 20ML
ATC code C07AG
ATC description BETA BLOCKING AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-12-20
Estimated end date 2019-02-04
Actual end date 2019-01-25
Shortage status Resolved
Updated date 2019-02-04
Company comments • Limited Stock /Inventaire limité : Stock available at some wholesalers with a MOQ in place /Inventaire disponible chez certains grossistes avec MOQ en place
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2019-02-04 French Compare
v4 2019-02-04 English Compare
v3 2018-12-21 English Compare
v2 2018-12-20 French Compare
v1 2018-12-20 English Compare

Showing 1 to 5 of 5